Zimmer Biomet Holdings ROE 2006-2020 | ZBH

Current and historical return on equity (ROE) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Zimmer Biomet Holdings ROE for the three months ending March 31, 2020 was 13.29%.
Zimmer Biomet Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $0.38B $11.88B 3.14%
2019-12-31 $1.13B $12.39B 9.50%
2019-09-30 $-0.09B $12.09B -0.77%
2019-06-30 $-0.36B $11.66B -3.07%
2019-03-31 $-0.31B $11.54B -2.62%
2018-12-31 $-0.38B $11.28B -3.19%
2018-09-30 $1.75B $12.22B 14.61%
2018-06-30 $1.69B $12.04B 14.62%
2018-03-31 $1.69B $12.00B 15.19%
2017-12-31 $1.81B $11.74B 17.10%
2017-09-30 $0.65B $10.45B 6.47%
2017-06-30 $0.71B $10.28B 7.19%
2017-03-31 $0.50B $9.93B 5.11%
2016-12-31 $0.31B $9.67B 3.18%
2016-09-30 $0.36B $9.75B 3.75%
2016-06-30 $0.23B $9.55B 2.32%
2016-03-31 $0.08B $9.66B 0.85%
2015-12-31 $0.15B $9.89B 1.60%
2015-09-30 $0.17B $9.99B 2.02%
2015-06-30 $0.32B $10.13B 4.28%
2015-03-31 $0.67B $6.58B 10.26%
2014-12-31 $0.72B $6.55B 11.19%
2014-09-30 $0.83B $6.54B 12.96%
2014-06-30 $0.81B $6.45B 12.86%
2014-03-31 $0.78B $6.24B 12.75%
2013-12-31 $0.78B $6.30B 12.98%
2013-09-30 $0.68B $6.14B 11.49%
2013-06-30 $0.70B $5.89B 12.05%
2013-03-31 $0.77B $5.71B 13.23%
2012-12-31 $0.76B $5.87B 13.11%
2012-09-30 $0.76B $5.83B 13.38%
2012-06-30 $0.77B $5.71B 13.76%
2012-03-31 $0.76B $5.66B 13.38%
2011-12-31 $0.76B $5.52B 13.25%
2011-09-30 $0.64B $5.61B 11.01%
2011-06-30 $0.64B $6.02B 10.89%
2011-03-31 $0.60B $5.86B 10.37%
2010-12-31 $0.60B $5.77B 10.36%
2010-09-30 $0.72B $5.82B 12.52%
2010-06-30 $0.68B $5.74B 11.72%
2010-03-31 $0.72B $5.71B 12.45%
2009-12-31 $0.72B $5.64B 12.48%
2009-09-30 $0.73B $5.98B 12.70%
2009-06-30 $0.80B $5.81B 14.05%
2009-03-31 $0.81B $5.56B 14.54%
2008-12-31 $0.85B $5.65B 15.10%
2008-09-30 $0.95B $5.62B 16.96%
2008-06-30 $0.78B $5.51B 14.15%
2008-03-31 $0.78B $5.71B 14.38%
2007-12-31 $0.77B $5.45B 14.67%
2007-09-30 $0.76B $5.25B 14.68%
2007-06-30 $0.89B $5.28B 17.75%
2007-03-31 $0.86B $5.12B 17.47%
2006-12-31 $0.84B $4.92B 17.09%
2006-09-30 $0.79B $4.80B 16.37%
2006-06-30 $0.78B $4.90B 16.33%
2006-03-31 $0.77B $4.92B 16.64%
2005-12-31 $0.73B $4.68B 16.64%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.894B $7.982B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.141B 28.29
Medtronic (MDT) Ireland $124.955B 20.30
Stryker (SYK) United States $68.946B 22.38
Boston Scientific (BSX) United States $49.509B 23.28
Baxter (BAX) United States $44.233B 27.00
Lonza Group Ag (LZAGY) Switzerland $39.871B 0.00
Terumo (TRUMY) Japan $29.963B 38.30
EssilorLuxottica Societe Anonyme (ESLOY) France $28.693B 0.00
ResMed (RMD) United States $27.846B 43.95
Smith & Nephew SNATS (SNN) United Kingdom $17.257B 0.00
Sunny Optical Technology (SNPTF) China $16.924B 0.00
Bio-Rad Laboratories (BIO) United States $13.589B 61.86
Insulet (PODD) United States $12.687B 1256.94
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.535B 74.93
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Perrigo (PRGO) Ireland $7.523B 13.46
Hill-Rom Holdings (HRC) United States $7.426B 20.93
GN STORE NORD (GNNDY) Denmark $6.972B 0.00
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.771B 0.00
Haemonetics (HAE) United States $4.656B 27.96
Neogen (NEOG) United States $4.108B 69.58
GW Pharmaceuticals (GWPH) United Kingdom $3.892B 0.00
ICU Medical (ICUI) United States $3.890B 28.38
Agios Pharmaceuticals (AGIO) United States $3.836B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.805B 0.00
Envista Holdings (NVST) United States $3.407B 0.00
NuVasive (NUVA) United States $2.925B 23.49
National Vision Holdings (EYE) United States $2.458B 42.53
TG Therapeutics (TGTX) United States $2.213B 0.00
AtriCure (ATRC) United States $1.855B 0.00
MacroGenics (MGNX) United States $1.450B 0.00
Aurora Cannabis (ACB) Canada $1.390B 0.00
NanoString Technologies (NSTG) United States $1.322B 0.00
Aphria (APHA) Canada $1.231B 0.00
Cardiovascular Systems (CSII) United States $1.137B 0.00
Cerus (CERS) United States $1.109B 0.00
Phibro Animal Health (PAHC) United States $1.055B 21.02
Meridian Bioscience (VIVO) United States $1.019B 38.37
PetIQ (PETQ) United States $1.017B 29.37
DFB Healthcare Acquisitions (AHCO) United States $0.924B 153.85
InMode (INMD) Israel $0.897B 18.97
Vapotherm (VAPO) United States $0.881B 0.00
Zynex (ZYXI) United States $0.834B 83.73
Omeros (OMER) United States $0.826B 0.00
Quanterix (QTRX) United States $0.789B 0.00
OraSure Technologies (OSUR) United States $0.746B 150.25
Eagle Pharmaceuticals (EGRX) United States $0.663B 47.51
Surmodics (SRDX) United States $0.585B 70.49
VAREX IMAGING (VREX) United States $0.584B 14.50
Lantheus Holdings (LNTH) United States $0.579B 11.65
LeMaitre Vascular (LMAT) United States $0.532B 30.29
BioLife Solutions (BLFS) United States $0.467B 163.45
Owens & Minor (OMI) United States $0.464B 12.27
Repro-Med Systems (KRMD) United States $0.394B 302.33
Viemed Healthcare (VMD) United States $0.367B 32.55
Cytosorbents (CTSO) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.315B 22.85
HEXO (HEXO) $0.311B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.304B 0.00
Organigram Holdings (OGI) Canada $0.285B 0.00
Female Health (VERU) United States $0.229B 0.00
Chimerix (CMRX) United States $0.196B 0.00
Bovie Medical (APYX) United States $0.185B 0.00
Evolus (EOLS) United States $0.185B 0.00
Surface Oncology (SURF) United States $0.178B 0.00
Exagen (XGN) United States $0.161B 0.00
Fonar (FONR) United States $0.135B 11.94
Rockwell Medical (RMTI) United States $0.133B 0.00
United Health Products (UEEC) United States $0.131B 0.00
Liberty Health Sciences (LHSIF) Canada $0.120B 0.00
Wound Management Technologies (SMTI) United States $0.112B 0.00
MTech Acquisition (KERN) United States $0.109B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.082B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.071B 16.51
Capricor Therapeutics (CAPR) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.055B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.012B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00